Skip to main content
Back
Watch Compare

BIOADAPTIVES, INC.

Data quality: 100%
BDPT
OTC Manufacturing Chemicals
$0.01
▼ $0.00 (-16.67%)
Mkt Cap: 120,086.0
Price
$0.01
Mkt Cap
120,086.0
Day Range
$0.01 — $0.01
52-Week Range
$0.01 — $0.12
Volume
2
Open $0.01
50D / 200D Avg
$0.02
52.38% below
50D / 200D Avg
$0.04
75.90% below

Quick Summary

Key Takeaways

Revenue declined -6.14% annually over 5 years
Negative free cash flow of -478,735.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 49.51%

Growth

Revenue Growth (5Y)
-6.14%
Below sector avg (9.35%)
Revenue (1Y)-55.65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-14091.71%
Op. Margin-14410.84%

Safety

Debt / Equity
N/A
Current Ratio0.07
Interest Coverage-26.22

Valuation

PE (TTM)
-0.11
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.1 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -14091.7 -150.2
Rev Growth 5Y % -6.1 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -55.65% Revenue Growth (3Y) -14.12%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -6.14% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7,851.0 Net Income (TTM) -1.11 M
ROE N/A ROA -557.53%
Gross Margin 62.59% Operating Margin -14410.84%
Net Margin -14091.71% Free Cash Flow (TTM) -478,735.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.07
Interest Coverage -26.22 Asset Turnover 0.04
Working Capital -1.48 M Tangible Book Value -1.47 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.11 Forward P/E N/A
P/B Ratio N/A P/S Ratio 15.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -398.66%
Market Cap 120,086.0 Enterprise Value 120,086.0
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share -0.04 OCF / Share -0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 43.27%
SBC-Adj. FCF -712,405 Growth Momentum -49.51

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 12,669.0 28,565.0 17,176.0 19,776.0 16,327.0
Net Income -899,161.0 -712,466.0 -895,570.0 -1.05 M -847,244.0
EPS (Diluted) — — — — —
Gross Profit 4,030.0 10,819.0 7,126.0 10,105.0 6,095.0
Operating Income -602,090.0 -228,921.0 — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 91,978.0 162,891.0 289,121.0 272,394.0 230,328.0
Income Tax — — 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 261,885.0 103,998.0 37,314.0 148,585.0 18,846.0
Total Liabilities 1.73 M 1.75 M 1.49 M 1.24 M 1.40 M
Shareholders' Equity -1.46 M -1.65 M -1.45 M -1.09 M -1.38 M
Total Debt — — — — —
Cash & Equivalents 261,885.0 60,776.0 25,405.0 — 4,587.0
Current Assets 261,885.0 88,557.0 34,324.0 88,876.0 18,846.0
Current Liabilities 1.73 M 1.75 M 1.49 M 1.24 M 1.40 M